Coexistence of KRAS mutation with mutant but not wild-type EGFR predicts response to tyrosine-kinase inhibitors in human lung cancer

Detalles Bibliográficos
Autores principales: Choughule, A, Sharma, R, Trivedi, V, Thavamani, A, Noronha, V, Joshi, A, Desai, S, Chandrani, P, Sundaram, P, Utture, S, Jambhekar, N, Gupta, S, Aich, J, Prabhash, K, Dutt, A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4260019/
https://www.ncbi.nlm.nih.gov/pubmed/25117816
http://dx.doi.org/10.1038/bjc.2014.401
_version_ 1782348107580702720
author Choughule, A
Sharma, R
Trivedi, V
Thavamani, A
Noronha, V
Joshi, A
Desai, S
Chandrani, P
Sundaram, P
Utture, S
Jambhekar, N
Gupta, S
Aich, J
Prabhash, K
Dutt, A
author_facet Choughule, A
Sharma, R
Trivedi, V
Thavamani, A
Noronha, V
Joshi, A
Desai, S
Chandrani, P
Sundaram, P
Utture, S
Jambhekar, N
Gupta, S
Aich, J
Prabhash, K
Dutt, A
author_sort Choughule, A
collection PubMed
description
format Online
Article
Text
id pubmed-4260019
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-42600192014-12-12 Coexistence of KRAS mutation with mutant but not wild-type EGFR predicts response to tyrosine-kinase inhibitors in human lung cancer Choughule, A Sharma, R Trivedi, V Thavamani, A Noronha, V Joshi, A Desai, S Chandrani, P Sundaram, P Utture, S Jambhekar, N Gupta, S Aich, J Prabhash, K Dutt, A Br J Cancer Letter to the Editor Nature Publishing Group 2014-11-25 2014-08-12 /pmc/articles/PMC4260019/ /pubmed/25117816 http://dx.doi.org/10.1038/bjc.2014.401 Text en Copyright © 2014 Cancer Research UK http://creativecommons.org/licenses/by-nc-sa/3.0/ This work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
spellingShingle Letter to the Editor
Choughule, A
Sharma, R
Trivedi, V
Thavamani, A
Noronha, V
Joshi, A
Desai, S
Chandrani, P
Sundaram, P
Utture, S
Jambhekar, N
Gupta, S
Aich, J
Prabhash, K
Dutt, A
Coexistence of KRAS mutation with mutant but not wild-type EGFR predicts response to tyrosine-kinase inhibitors in human lung cancer
title Coexistence of KRAS mutation with mutant but not wild-type EGFR predicts response to tyrosine-kinase inhibitors in human lung cancer
title_full Coexistence of KRAS mutation with mutant but not wild-type EGFR predicts response to tyrosine-kinase inhibitors in human lung cancer
title_fullStr Coexistence of KRAS mutation with mutant but not wild-type EGFR predicts response to tyrosine-kinase inhibitors in human lung cancer
title_full_unstemmed Coexistence of KRAS mutation with mutant but not wild-type EGFR predicts response to tyrosine-kinase inhibitors in human lung cancer
title_short Coexistence of KRAS mutation with mutant but not wild-type EGFR predicts response to tyrosine-kinase inhibitors in human lung cancer
title_sort coexistence of kras mutation with mutant but not wild-type egfr predicts response to tyrosine-kinase inhibitors in human lung cancer
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4260019/
https://www.ncbi.nlm.nih.gov/pubmed/25117816
http://dx.doi.org/10.1038/bjc.2014.401
work_keys_str_mv AT choughulea coexistenceofkrasmutationwithmutantbutnotwildtypeegfrpredictsresponsetotyrosinekinaseinhibitorsinhumanlungcancer
AT sharmar coexistenceofkrasmutationwithmutantbutnotwildtypeegfrpredictsresponsetotyrosinekinaseinhibitorsinhumanlungcancer
AT trivediv coexistenceofkrasmutationwithmutantbutnotwildtypeegfrpredictsresponsetotyrosinekinaseinhibitorsinhumanlungcancer
AT thavamania coexistenceofkrasmutationwithmutantbutnotwildtypeegfrpredictsresponsetotyrosinekinaseinhibitorsinhumanlungcancer
AT noronhav coexistenceofkrasmutationwithmutantbutnotwildtypeegfrpredictsresponsetotyrosinekinaseinhibitorsinhumanlungcancer
AT joshia coexistenceofkrasmutationwithmutantbutnotwildtypeegfrpredictsresponsetotyrosinekinaseinhibitorsinhumanlungcancer
AT desais coexistenceofkrasmutationwithmutantbutnotwildtypeegfrpredictsresponsetotyrosinekinaseinhibitorsinhumanlungcancer
AT chandranip coexistenceofkrasmutationwithmutantbutnotwildtypeegfrpredictsresponsetotyrosinekinaseinhibitorsinhumanlungcancer
AT sundaramp coexistenceofkrasmutationwithmutantbutnotwildtypeegfrpredictsresponsetotyrosinekinaseinhibitorsinhumanlungcancer
AT uttures coexistenceofkrasmutationwithmutantbutnotwildtypeegfrpredictsresponsetotyrosinekinaseinhibitorsinhumanlungcancer
AT jambhekarn coexistenceofkrasmutationwithmutantbutnotwildtypeegfrpredictsresponsetotyrosinekinaseinhibitorsinhumanlungcancer
AT guptas coexistenceofkrasmutationwithmutantbutnotwildtypeegfrpredictsresponsetotyrosinekinaseinhibitorsinhumanlungcancer
AT aichj coexistenceofkrasmutationwithmutantbutnotwildtypeegfrpredictsresponsetotyrosinekinaseinhibitorsinhumanlungcancer
AT prabhashk coexistenceofkrasmutationwithmutantbutnotwildtypeegfrpredictsresponsetotyrosinekinaseinhibitorsinhumanlungcancer
AT dutta coexistenceofkrasmutationwithmutantbutnotwildtypeegfrpredictsresponsetotyrosinekinaseinhibitorsinhumanlungcancer

Ejemplares similares